{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:28:06Z","timestamp":1793813286752,"version":"4.6.1"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH085953"],"award-info":[{"award-number":["R01MH085953"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["5U01MH119740 - 03"],"award-info":[{"award-number":["5U01MH119740 - 03"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH119741-01"],"award-info":[{"award-number":["U01MH119741-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"Stichting Steun 22Q11"},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UCLA CTSI UL1TR001881"],"award-info":[{"award-number":["UCLA CTSI UL1TR001881"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCLA Friends of the Semel Institute Research Scholar Award, Harvey L. and Maud C. Sorensen Foundation Fellowship"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"The SickKids Psychiatry Associates Chair in Developmental Psychopathology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recently, increasing numbers of rare pathogenic genetic variants have been identified that are associated with variably elevated risks of a range of neurodevelopmental outcomes, notably including Autism Spectrum Disorders (ASD), Schizophrenia Spectrum Disorders (SSD), and Intellectual Disability (ID). This review is organized along three main questions: First, how can we unify the exclusively descriptive basis of our current psychiatric diagnostic classification system with the recognition of an identifiable, highly penetrant genetic risk factor in an increasing proportion of patients with ASD or SSD? Second, what can be learned from studies of individuals with ASD or SSD who share a common genetic basis? And third, what accounts for the observed variable penetrance and pleiotropy of neuropsychiatric phenotypes in individuals with the same pathogenic variant? In this review, we focus on findings of clinical and preclinical studies of the 22q11.2 deletion syndrome (22q11DS). This particular variant is not only one of the most common among the increasing list of known rare pathogenic variants, but also one that benefits from a relatively long research history. Consequently, 22q11DS is an appealing model as it allows us to: (1) elucidate specific genotype\u2013phenotype associations, (2) prospectively study behaviorally defined classifications, such as ASD or SSD, in the context of a known, well-characterized genetic basis, and (3) elucidate mechanisms underpinning variable penetrance and pleiotropy, phenomena with far-reaching ramifications for research and clinical practice. We discuss how findings from animal and in vitro\n                    <jats:italic>s<\/jats:italic>\n                    tudies relate to observations in human studies and can help elucidate factors, including genetic, environmental, and stochastic, that impact the expression of neuropsychiatric phenotypes in 22q11DS, and how this may inform mechanisms underlying neurodevelopmental expression in the general population. We conclude with research priorities for the field, which may pave the way for novel therapeutics.\n                  <\/jats:p>","DOI":"10.1038\/s41380-022-01783-5","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T07:02:42Z","timestamp":1664780562000},"page":"341-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-7721","authenticated-orcid":false,"given":"Ania M.","family":"Fiksinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Hoftman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-3126","authenticated-orcid":false,"given":"Jacob A. S.","family":"Vorstman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-923X","authenticated-orcid":false,"given":"Carrie E.","family":"Bearden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","volume":"1","author":"DM McDonald-McGinn","year":"2015","unstructured":"McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JAS, et al. 22q11.2 deletion syndrome. Nat Rev Dis Prim. 2015;1:15071.","journal-title":"Nat Rev Dis Prim"},{"key":"1783_CR2","doi-asserted-by":"publisher","first-page":"E802","DOI":"10.9778\/cmajo.20200294","volume":"9","author":"C Blagojevic","year":"2021","unstructured":"Blagojevic C, Heung T, Theriault M, Tomita-Mitchell A, Chakraborty P, Kernohan K, et al. Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening. CMAJ Open. 2021;9:E802\u20139.","journal-title":"CMAJ Open"},{"key":"1783_CR3","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/ajmg.a.40387","volume":"176","author":"AM Fiksinski","year":"2018","unstructured":"Fiksinski AM, Schneider M, Murphy CM, Armando M, Vicari S, Canyelles JM, et al. Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome. Am J Med Genet A. 2018;176:2182\u201391.","journal-title":"Am J Med Genet A."},{"key":"1783_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.biopsych.2013.07.019","volume":"75","author":"RK Jonas","year":"2014","unstructured":"Jonas RK, Montojo CA, Bearden CE. The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol Psychiatry. 2014;75:351\u201360.","journal-title":"Biol Psychiatry"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ridd.2008.10.007","volume":"30","author":"L Niklasson","year":"2009","unstructured":"Niklasson L, Rasmussen P, Oskarsd\u00f3ttir S, Gillberg C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil. 2009;30:763\u201373.","journal-title":"Res Dev Disabil"},{"key":"1783_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/ijms18051071","volume":"18","author":"O Ousley","year":"2017","unstructured":"Ousley O, Evans AN, Fernandez-Carriba S, Smearman EL, Rockers K, Morrier MJ, et al. Examining the overlap between Autism Spectrum Disorder and 22q11.2 deletion syndrome. Int J Mol Sci. 2017;18:1071.","journal-title":"Int J Mol Sci"},{"key":"1783_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.biopsych.2019.12.028","volume":"88","author":"A Lin","year":"2020","unstructured":"Lin A, Vajdi A, Kushan-Wells L, Helleman G, Hansen LP, Jonas RK, et al. Reciprocal copy number variations at 22q11.2 produce distinct and convergent neurobehavioral impairments relevant for Schizophrenia and Autism Spectrum Disorder. Biol Psychiatry. 2020;88:260\u201372.","journal-title":"Biol Psychiatry"},{"key":"1783_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1176\/appi.ajp.2013.13070864","volume":"171","author":"M Schneider","year":"2014","unstructured":"Schneider M, Debban\u00e9 M, Bassett AS, Chow EWC, Fung WLA, van den Bree M, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171:627\u201339.","journal-title":"Am J Psychiatry"},{"key":"1783_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajmg.1320440237","volume":"44","author":"DA Driscoll","year":"1992","unstructured":"Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, Goldberg RB, et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet. 1992;44:261\u20138.","journal-title":"Am J Med Genet"},{"key":"1783_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0888-7543(91)90501-5","volume":"10","author":"PJ Scambler","year":"1991","unstructured":"Scambler PJ, Carey AH, Wyse RK, Roach S, Dumanski JP, Nordenskjold M, et al. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991;10:201\u20136.","journal-title":"Genomics"},{"key":"1783_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0006-3223(99)00114-6","volume":"46","author":"AS Bassett","year":"1999","unstructured":"Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry. 1999;46:882\u201391.","journal-title":"Biol Psychiatry"},{"key":"1783_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","volume":"56","author":"KC Murphy","year":"1999","unstructured":"Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940\u20135.","journal-title":"Arch Gen Psychiatry"},{"key":"1783_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00125817-200101000-00017","volume":"3","author":"L Niklasson","year":"2001","unstructured":"Niklasson L, Rasmussen P, Oskarsd\u00f3ttir S, Gillberg C. Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet Med. 2001;3:79\u201384.","journal-title":"Genet Med"},{"key":"1783_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ajmg.1320420131","volume":"42","author":"RJ Shprintzen","year":"1992","unstructured":"Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet. 1992;42:141\u20132.","journal-title":"Am J Med Genet"},{"key":"1783_CR15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-019-0581-5","volume":"25","author":"SJ Sanders","year":"2019","unstructured":"Sanders SJ, Sahin M, Hostyk J, Thurm A, Jacquemont S, Avillach P, et al. A framework for the investigation of rare genetic disorders in neuropsychiatry. Nat Med. 2019;25:1477\u201387.","journal-title":"Nat Med"},{"key":"1783_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S2215-0366(19)30076-8","volume":"6","author":"JR Zinkstok","year":"2019","unstructured":"Zinkstok JR, Boot E, Bassett AS, Hiroi N, Butcher NJ, Vingerhoets C, et al. Neurobiological perspective of 22q11.2 deletion syndrome. Lancet Psychiatry. 2019;6:951\u201360.","journal-title":"Lancet Psychiatry"},{"key":"1783_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1176\/appi.ajp.2021.21040432","volume":"179","author":"S Jacquemont","year":"2022","unstructured":"Jacquemont S, Huguet G, Klein M, Chawner SJRA, Donald KA, van den Bree MBM, et al. Genes To mental health (G2MH): a framework to map the combined effects of rare and common variants on dimensions of cognition and psychopathology. Am J Psychiatry. 2022;179:189\u2013203.","journal-title":"Am J Psychiatry"},{"key":"1783_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-021-01225-z","volume":"23","author":"AM Fiksinski","year":"2021","unstructured":"Fiksinski AM, Schneider M, Zinkstok J, Baribeau D, Chawner SJRA, Vorstman JAS. Neurodevelopmental trajectories and psychiatric morbidity: lessons learned from the 22q11.2 deletion syndrome. Curr Psychiatry Rep. 2021;23:13.","journal-title":"Curr Psychiatry Rep."},{"key":"1783_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-clinpsy-081219-110503","volume":"17","author":"JN Constantino","year":"2021","unstructured":"Constantino JN, Charman T, Jones EJH. Clinical and translational implications of an emerging developmental substructure for autism. Annu Rev Clin Psychol. 2021;17:365\u201389.","journal-title":"Annu Rev Clin Psychol"},{"key":"1783_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nn.4524","volume":"20","author":"RKC Yuen","year":"2017","unstructured":"Yuen RKC, Merico D, Bookman M, Howe JL, Thiruvahindrapuram B, Patel RV, et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci. 2017;20:602\u201311.","journal-title":"Nat Neurosci"},{"key":"1783_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ajhg.2007.12.009","volume":"82","author":"CR Marshall","year":"2008","unstructured":"Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82:477\u201388.","journal-title":"Am J Hum Genet"},{"key":"1783_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature10945","volume":"485","author":"SJ Sanders","year":"2012","unstructured":"Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012;485:237\u201341.","journal-title":"Nature"},{"key":"1783_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1126\/science.1138659","volume":"316","author":"J Sebat","year":"2007","unstructured":"Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science 2007;316:445\u20139.","journal-title":"Science"},{"key":"1783_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrg.2017.4","volume":"18","author":"JAS Vorstman","year":"2017","unstructured":"Vorstman JAS, Parr JR, Moreno-De-Luca D, Anney RJL, Nurnberger JI, Hallmayer JF. Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet. 2017;18:362\u201376.","journal-title":"Nat Rev Genet"},{"key":"1783_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gde.2020.12.016","volume":"68","author":"BM Finucane","year":"2021","unstructured":"Finucane BM, Ledbetter DH, Vorstman JA. Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation. Curr Opin Genet Dev. 2021;68:1\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"1783_CR26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1176\/appi.ajp.160.9.1580","volume":"160","author":"AS Bassett","year":"2003","unstructured":"Bassett AS, Chow EWC, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The Schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003;160:1580\u20136.","journal-title":"Am J Psychiatry"},{"key":"1783_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10519-011-9468-z","volume":"41","author":"N Philip","year":"2011","unstructured":"Philip N, Bassett A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav Genet. 2011;41:403\u201312.","journal-title":"Behav Genet"},{"key":"1783_CR28","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s10803-006-0308-6","volume":"37","author":"KM Antshel","year":"2007","unstructured":"Antshel KM, Aneja A, Strunge L, Peebles J, Fremont WP, Stallone K, et al. Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J Autism Dev Disord. 2007;37:1776\u201386.","journal-title":"J Autism Dev Disord"},{"key":"1783_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/cch.12457","volume":"43","author":"T Alugo","year":"2017","unstructured":"Alugo T, Malone H, Sheehan A, Coyne I, Lawlor A, McNicholas F. Development of a 22q11DS psycho-educational programme: exploration of the views, concerns and educational needs of parents caring for children or adolescents with 22q11DS in relation to mental health issues. Child Care Health Dev. 2017;43:527\u201335.","journal-title":"Child Care Health Dev"},{"key":"1783_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejmg.2013.05.001","volume":"56","author":"MBM van den Bree","year":"2013","unstructured":"van den Bree MBM, Miller G, Mansell E, Thapar A, Flinter F, Owen MJ. The internet is parents\u2019 main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS). Eur J Med Genet. 2013;56:439\u201341.","journal-title":"Eur J Med Genet"},{"key":"1783_CR31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1349-7006.1996.tb00282.x","volume":"87","author":"CA Rubio","year":"1996","unstructured":"Rubio CA, Matthies M, Itabashi M, Hirota T. Image quantitation of intestinal metaplasia in entire gastrectomy specimens from Swedish and Japanese patients. Jpn J Cancer Res. 1996;87:711\u20137.","journal-title":"Jpn J Cancer Res"},{"key":"1783_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajhg.2020.11.013","volume":"108","author":"LG Biesecker","year":"2021","unstructured":"Biesecker LG, Adam MP, Alkuraya FS, Amemiya AR, Bamshad MJ, Beck AE, et al. A dyadic approach to the delineation of diagnostic entities in clinical genomics. Am J Hum Genet. 2021;108:8\u201315.","journal-title":"Am J Hum Genet"},{"key":"1783_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gde.2020.12.017","volume":"68","author":"J Vorstman","year":"2021","unstructured":"Vorstman J, Scherer SW. What a finding of gene copy number variation can add to the diagnosis of developmental neuropsychiatric disorders. Curr Opin Genet Dev. 2021;68:18\u201325.","journal-title":"Curr Opin Genet Dev"},{"key":"1783_CR34","doi-asserted-by":"publisher","first-page":"k1674","DOI":"10.1136\/bmj.k1674","volume":"361","author":"L Zwaigenbaum","year":"2018","unstructured":"Zwaigenbaum L, Penner M. Autism spectrum disorder: advances in diagnosis and evaluation. BMJ. 2018;361:k1674.","journal-title":"BMJ."},{"key":"1783_CR35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00213-013-3334-z","volume":"231","author":"JAS Vorstman","year":"2014","unstructured":"Vorstman JAS, Spooren W, Persico AM, Collier DA, Aigner S, Jagasia R, et al. Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology 2014;231:1063\u201378.","journal-title":"Psychopharmacology"},{"key":"1783_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s11689-021-09371-4","volume":"13","author":"AB Arnett","year":"2021","unstructured":"Arnett AB, Wang T, Eichler EE, Bernier RA. Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders. J Neurodev Disord. 2021;13:24.","journal-title":"J Neurodev Disord"},{"key":"1783_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0079-6123(08)63436-6","volume":"64","author":"M Wiesendanger","year":"1986","unstructured":"Wiesendanger M. Some concluding remarks about general concepts in studies of the skeletomotor system. Prog Brain Res. 1986;64:419\u201323.","journal-title":"Prog Brain Res"},{"key":"1783_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/pcn.12641","volume":"72","author":"N Hiroi","year":"2018","unstructured":"Hiroi N. Critical reappraisal of mechanistic links of copy number variants to dimensional constructs of neuropsychiatric disorders in mouse models. Psychiatry Clin Neurosci. 2018;72:301\u201321.","journal-title":"Psychiatry Clin Neurosci"},{"key":"1783_CR39","doi-asserted-by":"crossref","unstructured":"Hiroi N, Hiramoto T, Harper KM, Suzuki G, Boku S. Mouse models of 22q11.2-associated autism spectrum disorder. Autism Open Access. 2012;Suppl 1:001.","DOI":"10.4172\/2165-7890.S1-001"},{"key":"1783_CR40","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/hmg\/8.12.2229","volume":"8","author":"WL Kimber","year":"1999","unstructured":"Kimber WL, Hsieh P, Hirotsune S, Yuva-Paylor L, Sutherland HF, Chen A, et al. Deletion of 150 kb in the minimal DiGeorge\/velocardiofacial syndrome critical region in mouse. Hum Mol Genet. 1999;8:2229\u201337.","journal-title":"Hum Mol Genet"},{"key":"1783_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.mcn.2006.09.001","volume":"33","author":"DW Meechan","year":"2006","unstructured":"Meechan DW, Maynard TM, Wu Y, Gopalakrishna D, Lieberman JA, LaMantia AS. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. Mol Cell Neurosci. 2006;33:412\u201328.","journal-title":"Mol Cell Neurosci"},{"key":"1783_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuron.2015.11.036","volume":"89","author":"RA Piskorowski","year":"2016","unstructured":"Piskorowski RA, Nasrallah K, Diamantopoulou A, Mukai J, Hassan SI, Siegelbaum SA, et al. Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11.2 deletion syndrome. Neuron 2016;89:163\u201376.","journal-title":"Neuron"},{"key":"1783_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.138","volume":"40","author":"KL Stark","year":"2008","unstructured":"Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet. 2008;40:751\u201360.","journal-title":"Nat Genet"},{"key":"1783_CR44","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.18632\/oncotarget.714","volume":"3","author":"O Catalina-Rodriguez","year":"2012","unstructured":"Catalina-Rodriguez O, Kolukula VK, Tomita Y, Preet A, Palmieri F, Wellstein A, et al. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget 2012;3:1220\u201335.","journal-title":"Oncotarget"},{"key":"1783_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s11689-015-9113-x","volume":"7","author":"A Guna","year":"2015","unstructured":"Guna A, Butcher NJ, Bassett AS. Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. J Neurodev Disord. 2015;7:18.","journal-title":"J Neurodev Disord"},{"key":"1783_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/hmg\/5.5.633","volume":"5","author":"S Demczuk","year":"1996","unstructured":"Demczuk S, Thomas G, Aurias A. Isolation of a novel gene from the DiGeorge syndrome critical region with homology to Drosophila gdl and to human LAMC1 genes. Hum Mol Genet. 1996;5:633\u20138.","journal-title":"Hum Mol Genet"},{"key":"1783_CR47","doi-asserted-by":"publisher","first-page":"e1004998","DOI":"10.1371\/journal.pgen.1004998","volume":"11","author":"SJ Grice","year":"2015","unstructured":"Grice SJ, Liu JL, Webber C. Synergistic interactions between Drosophila orthologues of genes spanned by de novo human CNVs support multiple-hit models of autism. PLoS Genet. 2015;11:e1004998.","journal-title":"PLoS Genet"},{"key":"1783_CR48","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/mp.2013.92","volume":"18","author":"N Hiroi","year":"2013","unstructured":"Hiroi N, Takahashi T, Hishimoto A, Izumi T, Boku S, Hiramoto T. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol Psychiatry. 2013;18:1153\u201365.","journal-title":"Mol Psychiatry"},{"key":"1783_CR49","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","volume":"126","author":"B Planchez","year":"2019","unstructured":"Planchez B, Surget A, Belzung C. Animal models of major depression: drawbacks and challenges. J Neural Transm. 2019;126:1383\u2013408.","journal-title":"J Neural Transm."},{"key":"1783_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ajmg.b.32863","volume":"186","author":"P Wang","year":"2021","unstructured":"Wang P, Li M, Zhao A, Ma J. Application of animal experimental models in the research of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2021;186:209\u201327.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1783_CR51","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/ajmg.a.40504","volume":"176","author":"BE Morrow","year":"2018","unstructured":"Morrow BE, McDonald-McGinn DM, Emanuel BS, Vermeesch JR, Scambler PJ. Molecular genetics of 22q11.2 deletion syndrome. Am J Med Genet Part A. 2018;176:2070\u201381.","journal-title":"Am J Med Genet Part A"},{"key":"1783_CR52","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s41591-020-1043-9","volume":"26","author":"TA Khan","year":"2020","unstructured":"Khan TA, Revah O, Gordon A, Yoon SJ, Krawisz AK, Goold C, et al. Neuronal defects in a human cellular model of 22q11.2 deletion syndrome. Nat Med. 2020;26:1888\u201398.","journal-title":"Nat Med"},{"key":"1783_CR53","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fgene.2019.01365","volume":"10","author":"Q Du","year":"2019","unstructured":"Du Q, de la Morena MT, van Oers NSC. The genetics and epigenetics of 22q11.2 deletion syndrome. Front Genet. 2019;10:1365.","journal-title":"Front Genet"},{"key":"1783_CR54","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00439-020-02252-1","volume":"140","author":"M Jeanne","year":"2021","unstructured":"Jeanne M, Vuillaume ML, Ung DC, Vancollie VE, Wagner C, Collins SC, et al. Haploinsufficiency of the HIRA gene located in the 22q11 deletion syndrome region is associated with abnormal neurodevelopment and impaired dendritic outgrowth. Hum Genet. 2021;140:885\u201396.","journal-title":"Hum Genet"},{"key":"1783_CR55","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1523\/JNEUROSCI.2700-12.2013","volume":"33","author":"Y Ouchi","year":"2013","unstructured":"Ouchi Y, Banno Y, Shimizu Y, Ando S, Hasegawa H, Adachi K, et al. Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2. J Neurosci. 2013;33:9408\u201319.","journal-title":"J Neurosci"},{"key":"1783_CR56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuron.2019.04.013","volume":"102","author":"A Fernandez","year":"2019","unstructured":"Fernandez A, Meechan DW, Karpinski BA, Paronett EM, Bryan CA, Rutz HL, et al. Mitochondrial Dysfunction leads to cortical under-connectivity and cognitive impairment. Neuron 2019;102:1127\u20131142.e3","journal-title":"Neuron"},{"key":"1783_CR57","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1007\/s12035-020-02067-1","volume":"57","author":"AR Al-Absi","year":"2020","unstructured":"Al-Absi AR, Qvist P, Okujeni S, Khan AR, Glerup S, Sanchez C, et al. Layers II\/III of prefrontal cortex in Df(h22q11)\/+ mouse model of the 22q11.2 deletion display loss of Parvalbumin interneurons and modulation of neuronal morphology and excitability. Mol Neurobiol. 2020;57:4978\u201388.","journal-title":"Mol Neurobiol"},{"key":"1783_CR58","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1093\/cercor\/bhu285","volume":"25","author":"EM Paronett","year":"2015","unstructured":"Paronett EM, Meechan DW, Karpinski BA, LaMantia AS, Maynard TM. Ranbp1, deleted in DiGeorge\/22q11.2 deletion syndrome, is a Microcephaly gene that selectively disrupts layer 2\/3 cortical projection neuron generation. Cereb Cortex. 2015;25:3977\u201393.","journal-title":"Cereb Cortex"},{"key":"1783_CR59","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/ijnp\/pyz026","volume":"22","author":"N Hiroi","year":"2019","unstructured":"Hiroi N, Yamauchi T. Modeling and predicting developmental trajectories of neuropsychiatric dimensions associated with copy number variations. Int J Neuropsychopharmacol. 2019;22:488\u2013500.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1783_CR60","doi-asserted-by":"crossref","unstructured":"Hiramoto T, Sumiyoshi A, Yamauchi T, Tanigaki K, Shi Q, Kang G, et al. Tbx1, a gene encoded in 22q11.2 copy number variant, is a link between alterations in fimbria myelination and cognitive speed in mice. Mol Psychiatry. 2021.","DOI":"10.1101\/2021.03.29.437581"},{"key":"1783_CR61","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/archpsyc.58.2.203","volume":"58","author":"LA Glantz","year":"2001","unstructured":"Glantz LA, Lewis DA. Dendritic spine density in schizophrenia and depression. Arch Gen Psychiatry. 2001;58:203.","journal-title":"Arch Gen Psychiatry"},{"key":"1783_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archpsyc.55.3.215","volume":"55","author":"G Rajkowska","year":"1998","unstructured":"Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215\u201324.","journal-title":"Arch Gen Psychiatry"},{"key":"1783_CR63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/npp.2008.67","volume":"34","author":"RA Sweet","year":"2009","unstructured":"Sweet RA, Henteleff RA, Zhang W, Sampson AR, Lewis DA. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology. 2009;34:374\u201389.","journal-title":"Neuropsychopharmacology."},{"key":"1783_CR64","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jamapsychiatry.2014.1582","volume":"71","author":"GT Konopaske","year":"2014","unstructured":"Konopaske GT, Lange N, Coyle JT, Benes FM. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014;71:1323\u201331.","journal-title":"JAMA Psychiatry"},{"key":"1783_CR65","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.biopsych.2015.03.030","volume":"78","author":"D Datta","year":"2015","unstructured":"Datta D, Arion D, Corradi JP, Lewis DA. Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia. Biol Psychiatry. 2015;78:775\u201385.","journal-title":"Biol Psychiatry"},{"key":"1783_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1176\/appi.ajp.2016.16020204","volume":"174","author":"D Datta","year":"2017","unstructured":"Datta D, Arion D, Roman KM, Volk DW, Lewis DA. Altered expression of ARP2\/3 complex signaling pathway genes in prefrontal layer 3 pyramidal cells in schizophrenia. Am J Psychiatry. 2017;174:163\u201371.","journal-title":"Am J Psychiatry"},{"key":"1783_CR67","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41593-021-00967-6","volume":"24","author":"A Contractor","year":"2021","unstructured":"Contractor A, Ethell IM, Portera-Cailliau C. Cortical interneurons in autism. Nat Neurosci. 2021;24:1648\u201359.","journal-title":"Nat Neurosci"},{"key":"1783_CR68","first-page":"1931","volume":"27","author":"E Hashemi","year":"2017","unstructured":"Hashemi E, Ariza J, Rogers H, Noctor SC, Mart\u00ednez-Cerde\u00f1o V. The number of parvalbumin-expressing interneurons is decreased in the prefrontal cortex in autism. Cereb Cortex. 2017;27:1931\u201343.","journal-title":"Cereb Cortex"},{"key":"1783_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","volume":"35","author":"DA Lewis","year":"2012","unstructured":"Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012;35:57\u201367.","journal-title":"Trends Neurosci"},{"key":"1783_CR70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","volume":"477","author":"O Yizhar","year":"2011","unstructured":"Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O\u2019Shea DJ, et al. Neocortical excitation\/inhibition balance in information processing and social dysfunction. Nature 2011;477:171\u20138.","journal-title":"Nature"},{"key":"1783_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15793-9","volume":"7","author":"H Amin","year":"2017","unstructured":"Amin H, Marinaro F, De Pietri Tonelli D, Berdondini L. Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics. Sci Rep. 2017;7:15752.","journal-title":"Sci Rep"},{"key":"1783_CR72","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopsych.2017.11.029","volume":"83","author":"GD Hoftman","year":"2018","unstructured":"Hoftman GD, Dienel SJ, Bazmi HH, Zhang Y, Chen K, Lewis DA. Altered gradients of glutamate and gamma-aminobutyric acid transcripts in the cortical visuospatial working memory network in schizophrenia. Biol Psychiatry. 2018;83:670\u20139.","journal-title":"Biol Psychiatry"},{"key":"1783_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/archgenpsychiatry.2010.114","volume":"68","author":"D Arion","year":"2011","unstructured":"Arion D, Lewis DA. Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. Arch Gen Psychiatry. 2011;68:21\u201331.","journal-title":"Arch Gen Psychiatry"},{"key":"1783_CR74","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1126\/science.3291116","volume":"241","author":"P Rakic","year":"1988","unstructured":"Rakic P. Specification of cerebral cortical areas. Science 1988;241:170\u20136.","journal-title":"Science"},{"key":"1783_CR75","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrn2719","volume":"10","author":"P Rakic","year":"2009","unstructured":"Rakic P. Evolution of the neocortex: a perspective from developmental biology. Nat Rev Neurosci. 2009;10:724\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"1783_CR76","doi-asserted-by":"publisher","first-page":"16434","DOI":"10.1073\/pnas.0905696106","volume":"106","author":"DW Meechan","year":"2009","unstructured":"Meechan DW, Tucker ES, Maynard TM, LaMantia AS. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion\/DiGeorge syndrome. Proc Natl Acad Sci USA. 2009;106:16434\u201345.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1783_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.03.004","volume":"130","author":"DW Meechan","year":"2015","unstructured":"Meechan DW, Maynard TM, Tucker ES, Fernandez A, Karpinski BA, Rothblat LA, et al. Modeling a model: mouse genetics, 22q11.2 deletion syndrome, and disorders of cortical circuit development. Prog Neurobiol. 2015;130:1\u201328.","journal-title":"Prog Neurobiol"},{"key":"1783_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature22330","volume":"545","author":"F Birey","year":"2017","unstructured":"Birey F, Andersen J, Makinson CD, Islam S, Wei W, Huber N, et al. Assembly of functionally integrated human forebrain spheroids. Nature 2017;545:54\u20139.","journal-title":"Nature"},{"key":"1783_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature15526","volume":"527","author":"J Mertens","year":"2015","unstructured":"Mertens J, Wang QW, Kim Y, Yu DX, Pham S, Yang B, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 2015;527:95\u20139.","journal-title":"Nature"},{"key":"1783_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12918-016-0366-0","volume":"10","author":"M Lin","year":"2016","unstructured":"Lin M, Pedrosa E, Hrabovsky A, Chen J, Puliafito BR, Gilbert SR, et al. Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion. BMC Syst Biol. 2016;10:105.","journal-title":"BMC Syst Biol"},{"key":"1783_CR81","doi-asserted-by":"publisher","unstructured":"De Los Angeles A, Fernando MB, Hall NAL, Brennand KJ, Harrison PJ, Maher BJ, et al. Induced pluripotent stem cells in psychiatry: an overview and critical perspective. Biol Psychiatry. 2021. https:\/\/doi.org\/10.1016\/j.biopsych.2021.04.008.","DOI":"10.1016\/j.biopsych.2021.04.008"},{"key":"1783_CR82","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature10523","volume":"478","author":"HJ Kang","year":"2011","unstructured":"Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, et al. Spatio-temporal transcriptome of the human brain. Nature 2011;478:483\u20139.","journal-title":"Nature"},{"key":"1783_CR83","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1023\/A:1026773005303","volume":"23","author":"BK Goodman","year":"2000","unstructured":"Goodman BK, Rutberg J, Lin WW, Pulver AE, Thomas GH. Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome. J Inherit Metab Dis. 2000;23:847\u20138.","journal-title":"J Inherit Metab Dis"},{"key":"1783_CR84","doi-asserted-by":"publisher","first-page":"e25882","DOI":"10.1371\/journal.pone.0025882","volume":"6","author":"MJCM Magn\u00e9e","year":"2011","unstructured":"Magn\u00e9e MJCM, Lamme VAF, de Sain-van der Velden MGM, Vorstman JAS, Kemner C. Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome. PLoS ONE. 2011;6:e25882.","journal-title":"PLoS ONE"},{"key":"1783_CR85","doi-asserted-by":"crossref","unstructured":"Namavar Y, Duineveld DJ, Both GIA, Fiksinski AM, Vorstman JAS, Verhoeven-Duif NM, et al. Psychiatric phenotypes associated with hyperprolinemia: a systematic review. Am J Med Genet B Neuropsychiatr Genet. 2021.","DOI":"10.1002\/ajmg.b.32869"},{"key":"1783_CR86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/hmg\/ddl443","volume":"16","author":"G Raux","year":"2007","unstructured":"Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet. 2007;16:83\u201391.","journal-title":"Hum Mol Genet"},{"key":"1783_CR87","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/npp.2008.132","volume":"34","author":"JAS Vorstman","year":"2009","unstructured":"Vorstman JAS, Turetsky BI, Sijmens-Morcus MEJ, de Sain MG, Dorland B, Sprong M, et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 2009;34:739\u201346.","journal-title":"Neuropsychopharmacology"},{"key":"1783_CR88","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","volume":"570","author":"S Velasco","year":"2019","unstructured":"Velasco S, Kedaigle AJ, Simmons SK, Nash A, Rocha M, Quadrato G, et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. Nature 2019;570:523\u20137.","journal-title":"Nature"},{"key":"1783_CR89","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","volume":"16","author":"L Studer","year":"2015","unstructured":"Studer L, Vera E, Cornacchia D. Programming and reprogramming cellular age in the era of induced pluripotency. Cell Stem Cell. 2015;16:591\u2013600.","journal-title":"Cell Stem Cell"},{"key":"1783_CR90","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/WNL.0000000000000379","volume":"82","author":"EB Schneider","year":"2014","unstructured":"Schneider EB, Sur S, Raymont V, Duckworth J, Kowalski RG, Efron DT, et al. Functional recovery after moderate\/severe traumatic brain injury. Neurology 2014;82:1636\u201342.","journal-title":"Neurology"},{"key":"1783_CR91","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1176\/appi.ajp.2017.16121417","volume":"174","author":"AS Bassett","year":"2017","unstructured":"Bassett AS, Lowther C, Merico D, Costain G, Chow EWC, van Amelsvoort T, et al. Rare genome-wide copy number variation and expression of schizophrenia in 22q11.2 deletion syndrome. Am J Psychiatry. 2017;174:1054\u201363.","journal-title":"Am J Psychiatry"},{"key":"1783_CR92","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41591-020-1103-1","volume":"26","author":"RW Davies","year":"2020","unstructured":"Davies RW, Fiksinski AM, Breetvelt EJ, Williams NM, Hooper SR, Monfeuga T, et al. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nat Med. 2020;26:1912\u20138.","journal-title":"Nat Med"},{"key":"1783_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-021-00434-w","volume":"12","author":"JN Constantino","year":"2021","unstructured":"Constantino JN. New guidance to seekers of autism biomarkers: an update from studies of identical twins. Mol Autism. 2021;12:28.","journal-title":"Mol Autism"},{"key":"1783_CR94","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/13668250.2011.572548","volume":"36","author":"SL Einfeld","year":"2011","unstructured":"Einfeld SL, Ellis LA, Emerson E. Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Disabil. 2011;36:137\u201343.","journal-title":"J Intellect Dev Disabil"},{"key":"1783_CR95","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/CHI.0b013e3181b76683","volume":"48","author":"T Green","year":"2009","unstructured":"Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009;48:1060\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1783_CR96","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1007\/s10803-017-3165-6","volume":"47","author":"KE Wagner","year":"2017","unstructured":"Wagner KE, Kates WR, Fremont W, Antshel KM. Childhood predictors of young adult social functioning in 22q11.2 deletion syndrome. J Autism Dev Disord. 2017;47:2480\u2013501.","journal-title":"J Autism Dev Disord"},{"key":"1783_CR97","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.ridd.2012.12.003","volume":"34","author":"SR Hooper","year":"2013","unstructured":"Hooper SR, Curtiss K, Schoch K, Keshavan MS, Allen A, Shashi V. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Res Dev Disabil. 2013;34:1758\u201369.","journal-title":"Res Dev Disabil"},{"key":"1783_CR98","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1192\/bjp.bp.113.132324","volume":"204","author":"M Niarchou","year":"2014","unstructured":"Niarchou M, Zammit S, van Goozen SHM, Thapar A, Tierling HM, Owen MJ, et al. Psychopathology and cognition in children with 22q11.2 deletion syndrome. Br J Psychiatry. 2014;204:46\u201354.","journal-title":"Br J Psychiatry"},{"key":"1783_CR99","doi-asserted-by":"crossref","unstructured":"Fiksinski AM, Bearden CE, Bassett AS, Kahn RS, Zinkstok JR, Hooper SR, et al. A normative chart for cognitive development in a genetically selected population. Neuropsychopharmacology 2021.","DOI":"10.1038\/s41386-021-00988-6"},{"key":"1783_CR100","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamapsychiatry.2014.2671","volume":"72","author":"JAS Vorstman","year":"2015","unstructured":"Vorstman JAS, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry. 2015;72:377\u201385.","journal-title":"JAMA Psychiatry"},{"key":"1783_CR101","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/jamapsychiatry.2017.4327","volume":"75","author":"J Mollon","year":"2018","unstructured":"Mollon J, David AS, Zammit S, Lewis G, Reichenberg A. Course of cognitive development from Infancy to early adulthood in the psychosis spectrum. JAMA Psychiatry. 2018;75:270\u20139.","journal-title":"JAMA Psychiatry"},{"key":"1783_CR102","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1176\/appi.ajp.2008.07081242","volume":"165","author":"KA Woodberry","year":"2008","unstructured":"Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in Schizophrenia: a meta-analytic review. Am J Psychiatry. 2008;165:579\u201387.","journal-title":"Am J Psychiatry."},{"key":"1783_CR103","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.schres.2019.04.012","volume":"208","author":"M Pontillo","year":"2019","unstructured":"Pontillo M, Menghini D, Vicari S. Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: a longitudinal study. Schizophr Res. 2019;208:76\u201381.","journal-title":"Schizophr Res"},{"key":"1783_CR104","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1192\/bjp.bp.111.097139","volume":"200","author":"SN Duijff","year":"2012","unstructured":"Duijff SN, Klaassen PWJ, Veye HFNS de, Beemer FA, Sinnema G, Vorstman JAS. Cognitive development in children with 22q11.2 deletion syndrome. Br J Psychiatry. 2012;200:462\u20138.","journal-title":"Br J Psychiatry"},{"key":"1783_CR105","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","volume":"70","author":"RS Kahn","year":"2013","unstructured":"Kahn RS, Keefe RSE. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70:1107\u201312.","journal-title":"JAMA Psychiatry"},{"key":"1783_CR106","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajmg.c.31440","volume":"169","author":"C Lord","year":"2015","unstructured":"Lord C, Bishop S, Anderson D. Developmental trajectories as autism phenotypes. Am J Med Genet C Semin Med Genet. 2015;169:198\u2013208.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"1783_CR107","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/01.chi.0000228131.56956.c1","volume":"45","author":"JAS Vorstman","year":"2006","unstructured":"Vorstman JAS, Morcus MEJ, Duijff SN, Klaassen PWJ, Heineman-de Boer JA, Beemer FA, et al. The 22q11.2 deletion in children: high rate of Autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry. 2006;45:1104\u201313.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1783_CR108","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1192\/bjp.bp.116.187682","volume":"210","author":"FV Larson","year":"2017","unstructured":"Larson FV, Wagner AP, Jones PB, Tantam D, Lai MC, Baron-Cohen S, et al. Psychosis in autism: comparison of the features of both conditions in a dually affected cohort. Br J Psychiatry. 2017;210:269\u201375.","journal-title":"Br J Psychiatry"},{"key":"1783_CR109","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2010.11.031","volume":"1380","author":"BH King","year":"2011","unstructured":"King BH, Lord C. Is schizophrenia on the autism spectrum? Brain Res. 2011;1380:34\u201341.","journal-title":"Brain Res"},{"key":"1783_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00702-007-0798-1","volume":"115","author":"SE Mouridsen","year":"2008","unstructured":"Mouridsen SE, Rich B, Isager T. Psychiatric disorders in adults diagnosed as children with atypical autism. a case control study. J Neural Transm. 2008;115:135\u20138.","journal-title":"J Neural Transm."},{"key":"1783_CR111","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jamapsychiatry.2014.3059","volume":"72","author":"JP Selten","year":"2015","unstructured":"Selten JP, Lundberg M, Rai D, Magnusson C. Risks for nonaffective psychotic disorder and bipolar disorder in young people with autism spectrum disorder: a population-based study. JAMA Psychiatry. 2015;72:483\u20139.","journal-title":"JAMA Psychiatry"},{"key":"1783_CR112","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1017\/S0033291714000750","volume":"44","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB. A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence. Psychol Med. 2014;44:3229\u201338.","journal-title":"Psychol Med"},{"key":"1783_CR113","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jaac.2018.09.446","volume":"58","author":"JH Foss-Feig","year":"2019","unstructured":"Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, et al. Clinical profiles and conversion rates among young individuals with Autism Spectrum disorder who present to clinical high risk for psychosis services. J Am Acad Child Adolesc Psychiatry. 2019;58:582\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1783_CR114","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.schres.2017.01.032","volume":"188","author":"AM Fiksinski","year":"2017","unstructured":"Fiksinski AM, Breetvelt EJ, Duijff SN, Bassett AS, Kahn RS, Vorstman JAS. Autism spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study. Schizophr Res. 2017;188:59\u201362.","journal-title":"Schizophr Res"},{"key":"1783_CR115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.schres.2012.10.010","volume":"143","author":"JAS Vorstman","year":"2013","unstructured":"Vorstman JAS, Breetvelt EJ, Thode KI, Chow EWC, Bassett AS. Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion. Schizophr Res. 2013;143:55\u20139.","journal-title":"Schizophr Res"},{"key":"1783_CR116","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neubiorev.2015.04.012","volume":"55","author":"K Chisholm","year":"2015","unstructured":"Chisholm K, Lin A, Abu-Akel A, Wood SJ. The association between autism and schizophrenia spectrum disorders: a review of eight alternate models of co-occurrence. Neurosci Biobehav Rev. 2015;55:173\u201383.","journal-title":"Neurosci Biobehav Rev"},{"key":"1783_CR117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biopsych.2016.08.034","volume":"82","author":"SX Tang","year":"2017","unstructured":"Tang SX, Moore TM, Calkins ME, Yi JJ, Savitt A, Kohler CG, et al. The psychosis spectrum in 22q11.2 deletion syndrome is comparable to that of nondeleted youths. Biol Psychiatry. 2017;82:17\u201325.","journal-title":"Biol Psychiatry"},{"key":"1783_CR118","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/YCO.0000000000000324","volume":"30","author":"L Van","year":"2017","unstructured":"Van L, Boot E, Bassett AS. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia. Curr Opin Psychiatry. 2017;30:191\u20136.","journal-title":"Curr Opin Psychiatry"},{"key":"1783_CR119","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.mp.4001477","volume":"9","author":"A Sporn","year":"2004","unstructured":"Sporn A, Addington A, Reiss AL, Dean M, Gogtay N, Potocnik U, et al. 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry. 2004;9:225\u20136.","journal-title":"Mol Psychiatry"},{"key":"1783_CR120","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.1155174","volume":"320","author":"T Walsh","year":"2008","unstructured":"Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008;320:539\u201343.","journal-title":"Science"},{"key":"1783_CR121","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ajmg.c.31435","volume":"169","author":"A Swillen","year":"2015","unstructured":"Swillen A, McDonald-McGinn D. Developmental trajectories in 22q11.2 deletion syndrome. Am J Med Genet Part C Semin Med Genet. 2015;169:172\u201381.","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"1783_CR122","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1017\/S0033291717003142","volume":"48","author":"JO Nuninga","year":"2018","unstructured":"Nuninga JO, Bohlken MM, Koops S, Fiksinski AM, Mandl RCW, Breetvelt EJ, et al. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline. Psychol Med. 2018;48:1655\u201363.","journal-title":"Psychol Med"},{"key":"1783_CR123","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WCO.0b013e32835f1a30","volume":"26","author":"JAS Vorstman","year":"2013","unstructured":"Vorstman JAS, Ophoff RA. Genetic causes of developmental disorders. Curr Opin Neurol. 2013;26:128\u201336.","journal-title":"Curr Opin Neurol"},{"key":"1783_CR124","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/ajmg.a.40359","volume":"176","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Guo T, Fiksinski A, Breetvelt E, McDonald-McGinn DM, Crowley TB, et al. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects. Am J Med Genet A 2018;176:2172\u201381.","journal-title":"Am J Med Genet A"},{"key":"1783_CR125","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/schbul\/sbx005","volume":"43","author":"O Weisman","year":"2017","unstructured":"Weisman O, Guri Y, Gur RE, McDonald-McGinn DM, Calkins ME, Tang SX, et al. Subthreshold psychosis in 22q11.2 deletion syndrome: multisite naturalistic study. Schizophr Bull. 2017;43:1079\u201389.","journal-title":"Schizophr Bull"},{"key":"1783_CR126","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/09540261.2018.1433133","volume":"30","author":"JN Constantino","year":"2018","unstructured":"Constantino JN. Deconstructing autism: from unitary syndrome to contributory developmental endophenotypes. Int Rev Psychiatry. 2018;30:18\u201324.","journal-title":"Int Rev Psychiatry"},{"key":"1783_CR127","doi-asserted-by":"publisher","first-page":"29","DOI":"10.31887\/DCNS.2012.14.1\/smorris","volume":"14","author":"SE Morris","year":"2012","unstructured":"Morris SE, Cuthbert BN. Research domain criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci. 2012;14:29\u201337.","journal-title":"Dialogues Clin Neurosci"},{"key":"1783_CR128","first-page":"211","volume":"6","author":"M Jalbrzikowski","year":"2021","unstructured":"Jalbrzikowski M. Neuroimaging phenotypes associated with risk and resilience for psychosis and autism spectrum disorders in 22q11.2 microdeletion syndrome. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:211\u201324.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"1783_CR129","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/mp.2017.161","volume":"22","author":"RE Gur","year":"2017","unstructured":"Gur RE, Bassett AS, McDonald-McGinn DM, Bearden CE, Chow E, Emanuel BS, et al. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 deletion syndrome brain behavior consortium. Mol Psychiatry. 2017;22:1664\u201372.","journal-title":"Mol Psychiatry"},{"key":"1783_CR130","unstructured":"Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry. 2020."},{"key":"1783_CR131","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2015.143","volume":"21","author":"KE Tansey","year":"2016","unstructured":"Tansey KE, Rees E, Linden DE, Ripke S, Chambert KD, Moran JL, et al. Common alleles contribute to schizophrenia in CNV carriers. Mol Psychiatry. 2016;21:1085\u20139.","journal-title":"Mol Psychiatry"},{"key":"1783_CR132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1176\/appi.ajp.2018.17040467","volume":"176","author":"SE Bergen","year":"2019","unstructured":"Bergen SE, Ploner A, Howrigan D, CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium, O\u2019Donovan MC, Smoller JW, et al. Joint contributions of rare copy number variants and common SNPs to risk for Schizophrenia. Am J Psychiatry. 2019;176:29\u201335.","journal-title":"Am J Psychiatry"},{"key":"1783_CR133","doi-asserted-by":"crossref","unstructured":"Fiksinski AM, Heung T, Corral M, Breetvelt EJ, Costain G, Marshall CR, et al. Within-family influences on dimensional neurobehavioral traits in a high-risk genetic model. Psychol Med. 2021;1\u20139.","DOI":"10.1017\/S0033291720005279"},{"key":"1783_CR134","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/jir.12054","volume":"58","author":"TM Allen","year":"2014","unstructured":"Allen TM, Hersh J, Schoch K, Curtiss K, Hooper SR, Shashi V. Association of the family environment with behavioural and cognitive outcomes in children with chromosome 22q11.2 deletion syndrome. J Intellect Disabil Res. 2014;58:31\u201347.","journal-title":"J Intellect Disabil Res"},{"key":"1783_CR135","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10897-010-9309-x","volume":"19","author":"V Shashi","year":"2010","unstructured":"Shashi V, Keshavan M, Kaczorowski J, Schoch K, Lewandowski KE, McConkie-Rosell A, et al. Socioeconomic status and psychological function in children with chromosome 22q11.2 deletion syndrome: implications for genetic counseling. J Genet Couns. 2010;19:535\u201344.","journal-title":"J Genet Couns"},{"key":"1783_CR136","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1093\/schbul\/sby025","volume":"44 S","author":"M Armando","year":"2018","unstructured":"Armando M, Sandini C, Chambaz M, Schaer M, Schneider M, Eliez S. Coping strategies mediate the effect of stressful life events on schizotypal traits and psychotic symptoms in 22q11.2 deletion syndrome. Schizophr Bull. 2018;44 Suppl 2:S525\u201335.","journal-title":"Schizophr Bull"},{"key":"1783_CR137","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.psyneuen.2019.03.023","volume":"106","author":"EDA van Duin","year":"2019","unstructured":"van Duin EDA, Vaessen T, Kasanova Z, Viechtbauer W, Reininghaus U, Saalbrink P, et al. Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome. Psychoneuroendocrinology 2019;106:85\u201394.","journal-title":"Psychoneuroendocrinology"},{"key":"1783_CR138","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fpsyt.2020.00646","volume":"11","author":"C Sandini","year":"2020","unstructured":"Sandini C, Schneider M, Eliez S, Armando M. Association between parental anxiety and depression level and psychopathological symptoms in Offspring with 22q11.2 deletion syndrome. Front Psychiatry. 2020;11:646.","journal-title":"Front Psychiatry"},{"key":"1783_CR139","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1126\/science.aan6877","volume":"359","author":"A Kong","year":"2018","unstructured":"Kong A, Thorleifsson G, Frigge ML, Vilhjalmsson BJ, Young AI, Thorgeirsson TE, et al. The nature of nurture: effects of parental genotypes. Science 2018;359:424\u20138.","journal-title":"Science"},{"key":"1783_CR140","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fgene.2018.00735","volume":"9","author":"DB Schwab","year":"2018","unstructured":"Schwab DB, Casasa S, Moczek AP. On the reciprocally causal and constructive nature of developmental plasticity and robustness. Front Genet. 2018;9:735.","journal-title":"Front Genet"},{"key":"1783_CR141","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/hmg\/dds180","volume":"21","author":"KM Harper","year":"2012","unstructured":"Harper KM, Hiramoto T, Tanigaki K, Kang G, Suzuki G, Trimble W, et al. Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain. Hum Mol Genet. 2012;21:3489\u201399.","journal-title":"Hum Mol Genet"},{"key":"1783_CR142","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/hmg\/ddp086","volume":"18","author":"G Suzuki","year":"2009","unstructured":"Suzuki G, Harper KM, Hiramoto T, Sawamura T, Lee M, Kang G, et al. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Hum Mol Genet. 2009;18:1652\u201360.","journal-title":"Hum Mol Genet"},{"key":"1783_CR143","doi-asserted-by":"publisher","first-page":"D802","DOI":"10.1093\/nar\/gkt977","volume":"42","author":"G Koscielny","year":"2014","unstructured":"Koscielny G, Yaikhom G, Iyer V, Meehan TF, Morgan H, Atienza-Herrero J, et al. The international mouse phenotyping consortium web portal, a unified point of access for knockout mice and related phenotyping data. Nucleic Acids Res. 2014;42:D802\u2013809.","journal-title":"Nucleic Acids Res."},{"key":"1783_CR144","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/nn1562","volume":"8","author":"M Paterlini","year":"2005","unstructured":"Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, Mukai J, et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci. 2005;8:1586\u201394.","journal-title":"Nat Neurosci"},{"key":"1783_CR145","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nm.4240","volume":"23","author":"S Chun","year":"2017","unstructured":"Chun S, Du F, Westmoreland JJ, Han SB, Wang YD, Eddins D, et al. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion. Nat Med. 2017;23:39\u201348.","journal-title":"Nat Med"},{"key":"1783_CR146","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/npp.2010.100","volume":"35","author":"CMP O\u2019Tuathaigh","year":"2010","unstructured":"O\u2019Tuathaigh CMP, Hryniewiecka M, Behan A, Tighe O, Coughlan C, Desbonnet L, et al. Chronic adolescent exposure to \u0394-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology 2010;35:2262\u201373.","journal-title":"Neuropsychopharmacology"},{"key":"1783_CR147","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1017\/S1461145711001581","volume":"15","author":"CMP O\u2019Tuathaigh","year":"2012","unstructured":"O\u2019Tuathaigh CMP, Clarke G, Walsh J, Desbonnet L, Petit E, O\u2019Leary C, et al. Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. Int J Neuropsychopharmacol. 2012;15:1331\u201342.","journal-title":"Int J Neuropsychopharmacol."},{"key":"1783_CR148","doi-asserted-by":"publisher","first-page":"8709","DOI":"10.1523\/JNEUROSCI.2077-08.2008","volume":"28","author":"F Papaleo","year":"2008","unstructured":"Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci. 2008;28:8709\u201323.","journal-title":"J Neurosci"},{"key":"1783_CR149","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/mp.2013.133","volume":"19","author":"F Papaleo","year":"2014","unstructured":"Papaleo F, Burdick MC, Callicott JH, Weinberger DR. Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans. Mol Psychiatry. 2014;19:311\u20136.","journal-title":"Mol Psychiatry"},{"key":"1783_CR150","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1093\/cercor\/bhw229","volume":"26","author":"SR Nilsson","year":"2016","unstructured":"Nilsson SR, Fejgin K, Gastambide F, Vogt MA, Kent BA, Nielsen V, et al. Assessing the cognitive translational potential of a mouse model of the 22q11.2 microdeletion syndrome. Cereb Cortex. 2016;26:3991\u20134003.","journal-title":"Cereb Cortex"},{"key":"1783_CR151","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cercor\/bht308","volume":"25","author":"DW Meechan","year":"2015","unstructured":"Meechan DW, Rutz HLH, Fralish MS, Maynard TM, Rothblat LA, LaMantia AS. Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS. Cereb Cortex. 2015;25:1143\u201351.","journal-title":"Cereb Cortex"},{"key":"1783_CR152","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/mp.2015.190","volume":"21","author":"T Takahashi","year":"2016","unstructured":"Takahashi T, Okabe S, Broin P\u00d3, Nishi A, Ye K, Beckert MV, et al. Structure and function of neonatal social communication in a genetic mouse model of autism. Mol Psychiatry. 2016;21:1208\u201314.","journal-title":"Mol Psychiatry"},{"key":"1783_CR153","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1093\/hmg\/ddr404","volume":"20","author":"T Hiramoto","year":"2011","unstructured":"Hiramoto T, Kang G, Suzuki G, Satoh Y, Kucherlapati R, Watanabe Y, et al. Tbx1: identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model. Hum Mol Genet. 2011;20:4775\u201385.","journal-title":"Hum Mol Genet"},{"key":"1783_CR154","doi-asserted-by":"publisher","first-page":"eaar6637","DOI":"10.1126\/sciadv.aar6637","volume":"4","author":"A Sumitomo","year":"2018","unstructured":"Sumitomo A, Horike K, Hirai K, Butcher N, Boot E, Sakurai T, et al. A mouse model of 22q11.2 deletions: molecular and behavioral signatures of Parkinson\u2019s disease and schizophrenia. Sci Adv. 2018;4:eaar6637.","journal-title":"Sci Adv"},{"key":"1783_CR155","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ng1375","volume":"36","author":"J Mukai","year":"2004","unstructured":"Mukai J, Liu H, Burt RA, Swor DE, Lai WS, Karayiorgou M, et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet. 2004;36:725\u201331.","journal-title":"Nat Genet"},{"key":"1783_CR156","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41380-018-0078-5","volume":"25","author":"D Sun","year":"2020","unstructured":"Sun D, Ching CRK, Lin A, Forsyth JK, Kushan L, Vajdi A, et al. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: convergence with idiopathic psychosis and effects of deletion size. Mol Psychiatry. 2020;25:1822\u201334.","journal-title":"Mol Psychiatry"},{"key":"1783_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-020-00356-z","volume":"11","author":"M Gudbrandsen","year":"2020","unstructured":"Gudbrandsen M, Bletsch A, Mann C, Daly E, Murphy CM, Stoencheva V, et al. Neuroanatomical underpinnings of autism symptomatology in carriers and non-carriers of the 22q11.2 microdeletion. Mol Autism. 2020;11:46.","journal-title":"Mol Autism"},{"key":"1783_CR158","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-022-04492-9","volume":"603","author":"S Marek","year":"2022","unstructured":"Marek S, Tervo-Clemmens B, Calabro FJ, Montez DF, Kay BP, Hatoum AS, et al. Reproducible brain-wide association studies require thousands of individuals. Nature 2022;603:654\u201360.","journal-title":"Nature"},{"key":"1783_CR159","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.gde.2021.03.002","volume":"68","author":"CA Moreau","year":"2021","unstructured":"Moreau CA, Ching CR, Kumar K, Jacquemont S, Bearden CE. Structural and functional brain alterations revealed by neuroimaging in CNV carriers. Curr Opin Genet Dev. 2021;68:88\u201398.","journal-title":"Curr Opin Genet Dev"},{"key":"1783_CR160","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/hbm.25354","volume":"43","author":"IE S\u00f8nderby","year":"2022","unstructured":"S\u00f8nderby IE, Ching CRK, Thomopoulos SI, van der Meer D, Sun D, Villalon-Reina JE, et al. Effects of copy number variations on brain structure and risk for psychiatric illness: large-scale studies from the ENIGMA working groups on CNVs. Hum Brain Mapp. 2022;43:300\u201328.","journal-title":"Hum Brain Mapp"},{"key":"1783_CR161","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI85594","volume":"127","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Ishizuka K, Nekooki-Machida Y, Endo R, Takashima N, Sasaki H, et al. Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington\u2019s disease. J Clin Investig. 2017;127:1438\u201350.","journal-title":"J Clin Investig"},{"key":"1783_CR162","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/YCO.0000000000000775","volume":"35","author":"D Baribeau","year":"2022","unstructured":"Baribeau D, Vorstman J, Anagnostou E. Novel treatments in autism spectrum disorder. Curr Opin Psychiatry. 2022;35:101\u201310.","journal-title":"Curr Opin Psychiatry"},{"key":"1783_CR163","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s13311-021-01082-x","volume":"18","author":"NA Copping","year":"2021","unstructured":"Copping NA, McTighe SM, Fink KD, Silverman JL. Emerging gene and small molecule therapies for the neurodevelopmental disorder Angelman Syndrome. Neurotherapeutics 2021;18:1535\u201347.","journal-title":"Neurotherapeutics"},{"key":"1783_CR164","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1093\/hmg\/ddv476","volume":"25","author":"AL Beaudet","year":"2016","unstructured":"Beaudet AL, Meng L. Gene-targeting pharmaceuticals for single-gene disorders. Hum Mol Genet. 2016;25:R18\u201326.","journal-title":"Hum Mol Genet"},{"key":"1783_CR165","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/genes12111667","volume":"12","author":"W Weuring","year":"2021","unstructured":"Weuring W, Geerligs J, Koeleman BPC. Gene therapies for monogenic autism spectrum disorders. Genes 2021;12:1667.","journal-title":"Genes"},{"key":"1783_CR166","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). Washington, DC: American Psychiatric Pub; 2013. p. 1414.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1783_CR167","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/chi.0b013e318068fc1f","volume":"46","author":"JAS Vorstman","year":"2007","unstructured":"Vorstman JAS, Morcus MEJ, van Engeland H. Psychopathology in 22q11 deletion syndrome. J Am Acad Child Adolesc Psychiatry. 2007;46:942\u20134.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1783_CR168","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1017\/S0140525X08004214","volume":"31","author":"B Crespi","year":"2008","unstructured":"Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci. 2008;31:241\u201361.","journal-title":"Behav Brain Sci."},{"key":"1783_CR169","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1176\/appi.ajp.2019.19060583","volume":"177","author":"CRK Ching","year":"2020","unstructured":"Ching CRK, Gutman BA, Sun D, Villalon Reina J, Ragothaman A, Isaev D, et al. Mapping subcortical brain alterations in 22q11.2 deletion syndrome: effects of deletion size and convergence with idiopathic neuropsychiatric Illness. AJP. 2020;177:589\u2013600.","journal-title":"AJP"},{"key":"1783_CR170","doi-asserted-by":"publisher","first-page":"e10887","DOI":"10.1371\/journal.pone.0010887","volume":"5","author":"H Bruining","year":"2010","unstructured":"Bruining H, de Sonneville L, Swaab H, de Jonge M, Kas M, van Engeland H, et al. Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes. PLoS ONE. 2010;5:e10887.","journal-title":"PLoS ONE"},{"key":"1783_CR171","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jaac.2010.07.001","volume":"49","author":"SS Hall","year":"2010","unstructured":"Hall SS, Lightbody AA, Hirt M, Rezvani A, Reiss AL. Autism in fragile X syndrome: a category mistake? J Am Acad Child Adolesc Psychiatry. 2010;49:921\u201333.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1783_CR172","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1176\/appi.ajp.2020.20010015","volume":"178","author":"SJRA Chawner","year":"2021","unstructured":"Chawner SJRA, Doherty JL, Anney RJL, Antshel KM, Bearden CE, Bernier R, et al. A genetics-first approach to dissecting the heterogeneity of Autism: phenotypic comparison of Autism risk copy number variants. Am J Psychiatry. 2021;178:77\u201386.","journal-title":"Am J Psychiatry"},{"key":"1783_CR173","doi-asserted-by":"publisher","first-page":"102033","DOI":"10.1016\/j.cpr.2021.102033","volume":"87","author":"JA Agelink van Rentergem","year":"2021","unstructured":"Agelink van Rentergem JA, Deserno MK, Geurts HM. Validation strategies for subtypes in psychiatry: a systematic review of research on autism spectrum disorder. Clin Psychol Rev. 2021;87:102033.","journal-title":"Clin Psychol Rev"},{"key":"1783_CR174","doi-asserted-by":"publisher","first-page":"e0167179","DOI":"10.1371\/journal.pone.0167179","volume":"11","author":"J Frohlich","year":"2016","unstructured":"Frohlich J, Senturk D, Saravanapandian V, Golshani P, Reiter LT, Sankar R, et al. A quantitative electrophysiological biomarker of duplication 15q11.2-q13.1 syndrome. PLoS ONE. 2016;11:e0167179.","journal-title":"PLoS ONE"},{"key":"1783_CR175","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2014.06.017","volume":"158","author":"R Bernier","year":"2014","unstructured":"Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 2014;158:263\u201376.","journal-title":"Cell"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01783-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T21:09:30Z","timestamp":1673125770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01783-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01783-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JASV has served as a consultant for NoBias Therapeutics Inc and received speaker fees from Henry Stewart Talks Ltd (both unrelated to the content of this manuscript). The authors declare no relevant financial disclosures or competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}